» Articles » PMID: 35508614

A Comprehensive Atlas of Aggrecan, Versican, Neurocan and Phosphacan Expression Across Time in Wildtype Retina and in Retinal Degeneration

Overview
Journal Sci Rep
Specialty Science
Date 2022 May 4
PMID 35508614
Authors
Affiliations
Soon will be listed here.
Abstract

As photoreceptor cells die during retinal degeneration, the surrounding microenvironment undergoes significant changes that are increasingly recognized to play a prominent role in determining the efficacy of therapeutic interventions. Chondroitin Sulphate Proteoglycans (CSPGs) are a major component of the extracellular matrix that have been shown to inhibit neuronal regrowth and regeneration in the brain and spinal cord, but comparatively little is known about their expression in retinal degeneration. Here we provide a comprehensive atlas of the expression patterns of four individual CSPGs in three models of inherited retinal degeneration and wildtype mice. In wildtype mice, Aggrecan presented a biphasic expression, while Neurocan and Phosphacan expression declined dramatically with time and Versican expression remained broadly constant. In degeneration, Aggrecan expression increased markedly in Aipl1 and Pde6b, while Versican showed regional increases in the periphery of Rho mice. Conversely, Neurocan and Phosphacan broadly decrease with time in all models. Our data reveal significant heterogeneity in the expression of individual CSPGs. Moreover, there are striking differences in the expression patterns of specific CSPGs in the diseased retina, compared with those reported following injury elsewhere in the CNS. Better understanding of the distinct distributions of individual CSPGs will contribute to creating more permissive microenvironments for neuro-regeneration and repair.

Citing Articles

Cpeb1 remodels cell type-specific translational program to promote fear extinction.

Zhang J, Yang C, Liu Z, Wu S, Li Z, Zhang L Sci Adv. 2025; 11(2):eadr8687.

PMID: 39792668 PMC: 11721575. DOI: 10.1126/sciadv.adr8687.


Multimodal Evaluation and Management of Wagner Syndrome-Three Patients from an Affected Family.

Szeligowski T, Cehajic-Kapetanovic J, Raji S, Purohit R, Amin H, Patel C Genes (Basel). 2024; 15(9).

PMID: 39336769 PMC: 11431714. DOI: 10.3390/genes15091178.


The mechanics of the retina: Müller glia role on retinal extracellular matrix and modelling.

Prieto-Lopez L, Pereiro X, Vecino E Front Med (Lausanne). 2024; 11:1393057.

PMID: 39296899 PMC: 11410058. DOI: 10.3389/fmed.2024.1393057.


Prominent elevation of extracellular matrix molecules in intracerebral hemorrhage.

Li H, Ghorbani S, Zhang R, Ebacher V, Stephenson E, Keough M Front Mol Neurosci. 2023; 16:1251432.

PMID: 38025264 PMC: 10658787. DOI: 10.3389/fnmol.2023.1251432.

References
1.
Mohan V, Wyatt E, Gotthard I, Phend K, Diestel S, Duncan B . Neurocan Inhibits Semaphorin 3F Induced Dendritic Spine Remodeling Through NrCAM in Cortical Neurons. Front Cell Neurosci. 2018; 12:346. PMC: 6189303. DOI: 10.3389/fncel.2018.00346. View

2.
Wu Y, La Pierre D, Wu J, Yee A, Yang B . The interaction of versican with its binding partners. Cell Res. 2005; 15(7):483-94. DOI: 10.1038/sj.cr.7290318. View

3.
Hippert C, Graca A, Barber A, West E, Smith A, Ali R . Müller glia activation in response to inherited retinal degeneration is highly varied and disease-specific. PLoS One. 2015; 10(3):e0120415. PMC: 4368159. DOI: 10.1371/journal.pone.0120415. View

4.
Nishiguchi K, Carvalho L, Rizzi M, Powell K, Kleine Holthaus S, Azam S . Gene therapy restores vision in rd1 mice after removal of a confounding mutation in Gpr179. Nat Commun. 2015; 6:6006. PMC: 4354202. DOI: 10.1038/ncomms7006. View

5.
Reinhard J, Renner M, Wiemann S, Shakoor D, Stute G, Dick H . Ischemic injury leads to extracellular matrix alterations in retina and optic nerve. Sci Rep. 2017; 7:43470. PMC: 5338032. DOI: 10.1038/srep43470. View